Loading…

Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2)

Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skele...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2018-05, Vol.151, p.777-796
Main Authors: Yu, Le-Mao, Hu, Zhu, Chen, Yu, Ravji, Azhar, Lopez, Sophia, Plescia, Caroline B., Yu, Qian, Yang, Hui, Abdelmalak, Monica, Saha, Sourav, Agama, Keli, Kiselev, Evgeny, Marchand, Christophe, Pommier, Yves, An, Lin-Kun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a recently discovered enzyme specifically repairing topoisomerase II (TOP2)-mediated DNA damage. It has been shown that inhibition of TDP2 synergize with TOP2 inhibitors. Herein, we report the discovery of the furoquinolinedione chemotype as a suitable skeleton for the development of selective TDP2 inhibitors. Compound 1 was identified as a TDP2 inhibitor as a result of screening our in-house compound library for compounds selective for TDP2 vs. TDP1. Further SAR studies provide several selective TDP2 inhibitors at low-micromolar range. The most potent compound 74 shows inhibitory activity with IC50 of 1.9 and 2.1 μM against recombinant TDP2 and TDP2 in whole cell extracts (WCE), respectively. [Display omitted] •A novel TDP2 hit (1) was found through screening from in-house chemical library.•Seventy seven furoquinolinedione analogues were synthesized.•Compound 74 showed the most TDP2 inhibition with IC50 at low micromolar range.•The SAR was analyzed.•Furoquinolinedinone chemotype represents a novel skeleton for novel TDP2 inhibitors.
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2018.04.024